RecruitingNCT05851989

Study on Prognosis of Acutely Ruptured Intracranial Aneurysms


Sponsor

Haaglanden Medical Centre

Enrollment

880 participants

Start Date

Jul 14, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The SPARTA study is a prospective multicenter observational trial in the Netherlands with the aim of identifying the best clinical care in patients with aneurysmal subarachnoidal haemorrhage. Differences in outcome between surgical treatment and endovascular treatment will be explored. Furthermore, cost effectiveness and radiological prognostic factors will be examined.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This Dutch observational study follows patients who have experienced a subarachnoid hemorrhage (SAH) caused by a ruptured brain aneurysm — a sudden and life-threatening event where a blood vessel in the brain bursts, flooding the space around the brain with blood. The study tracks long-term outcomes including survival, neurological function, quality of life, and risk of re-bleeding, aiming to better understand which patient and aneurysm factors predict good versus poor outcomes. This knowledge is essential for guiding treatment decisions. Adults 18 or older with a confirmed SAH caused by an intracranial aneurysm, diagnosed within six months, and who can provide written informed consent are eligible. Patients whose bleeding is from a traumatic injury, a perimesencephalic (low-risk) pattern, or from a vascular malformation other than an aneurysm are excluded, as are those who do not speak Dutch. Ruptured brain aneurysms are devastating — carrying a mortality rate of about 30-40% in the first month alone, and leaving many survivors with cognitive deficits, fatigue, and emotional difficulties. Despite advances in surgical and endovascular treatment, predicting who will recover well remains difficult. This registry-style study builds the long-term outcome data that clinicians need to counsel patients and families accurately, and that researchers need to design better treatments.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(6)

Amsterdam UMC

Amsterdam, Netherlands

Maastricht UMC

Maastricht, Netherlands

Radboudumc

Nijmegen, Netherlands

Erasmus MC

Rotterdam, Netherlands

Haaglanden Medical Center

The Hague, Netherlands

Universitair Medisch Centrum Utrecht

Utrecht, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05851989


Related Trials